Reply to letter: "5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure".

No abstract is available for this paper.

• Publication year

  2017

• Venue

  International Journal of Cardiology

• Publication date

  2017-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ijcard.2016.12.154PMID 28073661
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 5-Methoxytryptophan: A promising early marker for predicting post-myocardial infarction heart failure.

  2017cited by this paper
• 5-methoxytryptophan is a potential marker for post-myocardial infarction heart failure - a preliminary approach to clinical utility.

  2016cited by this paper
• Endothelium-Derived 5-Methoxytryptophan Is a Circulating Anti-Inflammatory Molecule That Blocks Systemic Inflammation.

  2016cited by this paper
• A Novel Protective Function of 5-Methoxytryptophan in Vascular Injury

  2016cited by this paper
• Endothelium-Derived 5-Methoxytryptophan Protects Endothelial Barrier Function by Blocking p38 MAPK Activation

  2016cited by this paper
• 5-Methoxytryptophan-dependent protection of cardiomyocytes from heart ischemia reperfusion injury.

  2014cited by this paper
• Quiescent and Proliferative Fibroblasts Exhibit Differential p300 HAT Activation through Control of 5-Methoxytryptophan Production

  2013cited by this paper

• The determination of 5-methoxytryptophan in human plasma.

  2018cites this paper